Enrique L. Alvarez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Stromal tumor infiltrating lymphocytes and TNBC-DX provide complementary prognostic information in triple-negative breast cancer.
Journal: Journal of the National Cancer Institute
Published: March 11, 2025
TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: July 20, 2024
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 09, 2024
Correlation between breast cancer subtypes determined by immunohistochemistry and n-COUNTER PAM50 assay: a real-world study.
Journal: Breast cancer research and treatment
Published: January 25, 2023
Tumor stem cells fuse with monocytes to form highly invasive tumor-hybrid cells.
Journal: Oncoimmunology
Published: September 14, 2020
Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid.
Journal: Frontiers in oncology
Published: July 10, 2020
Concordance of Genomic Variants in Matched Primary Breast Cancer, Metastatic Tumor, and Circulating Tumor DNA: The MIRROR Study.
Journal: JCO precision oncology
Published: December 01, 2019
Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series.
Journal: BMC genomics
Published: September 28, 2018
Pas Kinase Deficiency Triggers Antioxidant Mechanisms in the Liver.
Journal: Scientific reports
Published: April 05, 2018
PAS Kinase deficiency alters the glucokinase function and hepatic metabolism.
Journal: Scientific reports
Published: January 09, 2018
Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 05, 2017
Last Updated: 09/26/2026